Value of non-invasive fibrosis markers in chronic hepatitis D von Kalkan, C, Karakaya, F, Keskin, O, Kartal, A, Karatayli, E, Bozdayi, M, İdilman, R, Yurdcu, E, Yurdaydin, C

Volltext

A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study von Yurdaydin, C, Idilman, R, Keskin, O, Kalkan, C, Karakaya, M.F, Caliskan, A, Yurdcu, E, Karatayli, S.C, Bozdayi, M, Koh, C, Heller, T, Glenn, J

Volltext

The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis von Yurdaydin, C, Idilman, R, Kalkan, C, Karakaya, M.F, Caliskan, A, Keskin, O, Yurdcu, E, Karatayli, S.C, Bozdayi, M, Koh, C, Heller, T, Glenn, J

Volltext

FRI-142 - Value of non-invasive fibrosis markers in chronic hepatitis D von Kalkan, C., Karakaya, F., Keskin, O., Kartal, A., Karatayli, E., Bozdayi, M., İdilman, R., Yurdcu, E., Yurdaydin, C.

Volltext

THU-161 - The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of f... von Yurdaydin, C., Idilman, R., Kalkan, C., Karakaya, M.F., Caliskan, A., Keskin, O., Yurdcu, E., Karatayli, S.C., Bozdayi, M., Koh, C., Heller, T., Glenn, J.

Volltext

GS-008 - A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study von Yurdaydin, C., Idilman, R., Keskin, O., Kalkan, C., Karakaya, M.F., Caliskan, A., Yurdcu, E., Karatayli, S.C., Bozdayi, M., Koh, C., Heller, T., Glenn, J.

Volltext

A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis von Yurdaydin, Cihan, Keskin, Onur, Yurdcu, Esra, Çalişkan, Aysun, Önem, Soner, Karakaya, Fatih, Kalkan, Çağdaş, Karatayli, Ersin, Karatayli, Senem, Choong, Ingrid, Apelian, David, Koh, Christopher, Heller, Theo, Idilman, Ramazan, Bozdayi, A. Mithat, Glenn, Jeffrey S.

Volltext

Epidemiology of blood-borne viral infections in Afghanistan von Husseini, Abbas Ali, Saeed, Khwaja Mir Islam, Yurdcu, Esra, Sertoz, Rüçhan, Bozdayi, A. Mithat

Volltext

HEV seroprevalence in blood donors in Turkey by two commercial total anti‐HEV Ab ELISA kits von Yaşar, Osman, Karatayli, Ersin, Cengiz, Güniz, Kızılpınar, Mehtap, Yurdcu, Esra, Albayrak, Rabia, Güven, Aysel, Arslan, Önder, Karahan, Ceren, Otlu, Barış, Güdücüoğlu, Hüseyin, Gökahmetoğlu, Selma, Berk, Elife, Kirişci, Özlem, Sertöz, Rüçhan, Yurdaydin, Cihan, Bozdayi, A. Mithat, Karatayli, Senem Ceren

Volltext

Non‐invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta von Kalkan, Çağdaş, Yılmaz, Yusufcan, Erdoğan, Beyza Doğanay, Savaş, Berna, Yurdcu, Esra, Çalışkan, Aysun, Keskin, Onur, Gencdal, Genco, Zeybel, Müjdat, Törüner, Murat, Bozdayi, A. Mithat, Idilman, Ramazan, Yurdaydin, Cihan

Volltext

Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan von Husseini, Abbas Ali, Islam Saeed, Khwaja Mir, Yurdcu, Esra, Bozdayı, A Mithat

Volltext

Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping von AKINCI, Esragül, YURDCU, Esra, ORKUN ÖZBAY, Bahadır, BODUR, Hürrem

Volltext

Evaluation of the results of MOTAKK hepatitis C virus RNA genotyping and hepatitis delta virus external quality assessment programs during 2015-2016 von Karataylı, Ersin, Soydemir, Ege, Aksoy, Zeynep Büşra, Kızılpınar, Mehtap, Altay Koçak, Aylin, Karataylı, Senem Ceren, Yurdcu, Esra, Yıldırım, Umut, Güriz, Haluk, Bozdayı, Gülendam, Yurdaydın, Cihan, İlhan, Osman, Yıldırım, Yasin, Hdv Study Group, Motakk Hcv Genotype And, Bozdayı, A Mithat

Volltext

Evaluation of 2015-2016 MOTAKK HBV DNA and HCV RNA external quality assessment national program results von Karataylı, Ersin, Soydemir, Ege, Aksoy, Zeynep Büşra, Kızılpınar, Mehtap, Altay Koçak, Aylin, Karataylı, Senem Ceren, Yurdcu, Esra, Yıldırım, Umut, Güriz, Haluk, Bozdayı, Gülendam, Yurdaydın, Cihan, İlhan, Osman, Yıldırım, Yasin, Bozdayı, A Mithat

Volltext

Host-targeting antivirals for chronic viral infections of the liver von Frericks, Nicola, Klöhn, Mara, Lange, Frauke, Pottkämper, Lilli, Carpentier, Arnaud, Steinmann, Eike

Volltext

Higher Risk of HEV Transmission and Exposure among Blood Donors in Europe and Asia in Comparison to North America: A Meta-Analysis von Wolski, Annika, Pischke, Sven, Ozga, Ann-Kathrin, Addo, Marylyn M, Horvatits, Thomas

Volltext

First Report from Afghanistan on the Prevalence of Blood-Borne Infections: A Retrospective Cross-Sectional Multicentre Study for an Epidemiological Assessment von Hashemi, Enayatullah, Waheed, Usman, Saba, Noore, Wazeer, Akhlaaq

Volltext

Hepatitis D Virus Infection von Asselah, Tarik, Rizzetto, Mario

Volltext

A Review of HDV Infection von Caviglia, Gian Paolo, Ciancio, Alessia, Rizzetto, Mario

Volltext

Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022 von Lampertico, Pietro, Degasperi, Elisabetta, Sandmann, Lisa, Wedemeyer, Heiner, Yurdaydin, Cihan, Roulot, Dominique, Zoulim, Fabien, Caruntu, Florin Alexandru, Wedemeyer, Heiner, Kefalakes, Helenie, Lucifora, Julie, Agarwal, Kosh, Castera, Laurent, Buti, Maria, Rizzetto, Mario, Cornberg, Markus, Dandri, Maura, Brunetto, Maurizia, Reau, Nancy, Gish, Robert, Hamid, Saeed, Aleman, Soo, Urban, Stephan, Asselah, Tarik, Berg, Thomas, de Lédinghen, Victor

Volltext